Address
Forward Ventures Services LLC
9393 Towne Centre Drive
Suite 200
San Diego, CA 92121
United States
Phone
Website
Recent investment activity
KANDO id: 28814
Corporate information
Official name
Forward Ventures Services LLC
Also known as
Forward Ventures
Registration country
Funds managed
Fund | Type | Vintage | Currency | Committed capital |
---|---|---|---|---|
Forward V |
Funding rounds
Top investment portfolio themes
healthcare (1)
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 40Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Affinium Pharmaceuticals Ltd | Developing a novel class of antibiotics. | N/A | ||||
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | ||||
Asteres Inc | Commercialized a system to store and deliver finished prescriptions to consumers in retail pharmacy. | Series C | ||||
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A | ||||
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | ||||
Cellective Therapeutics Inc | N/A | |||||
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | ||||
Converge Medical Inc | N/A | |||||
Dynavax Technologies Corp | N/A | |||||
EPIX Pharmaceuticals Inc | N/A | |||||
Essentialis Inc | Developing a novel therapy for the treatment of dyslipidemia. | Series B | ||||
Hypnion Inc | N/A | |||||
Kemia Inc | N/A | |||||
LigoCyte Pharmaceuticals Inc | N/A | |||||
Micromet Inc | Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases | N/A | ||||
MMR Information Systems Inc (Favrille Inc) | N/A | |||||
Morphotek Inc | Biotechnology company focused on the generation of proprietary organisms for product discovery and development. | N/A | ||||
Nereus Pharmaceuticals Inc | Series E | |||||
Nereus Pharmaceuticals Inc | Series D | |||||
Nereus Pharmaceuticals Inc | N/A | |||||
Nereus Pharmaceuticals Inc | Series A | |||||
NovaCardia Inc | Cardiovascular pharmaceutical company focused on the development and commercialization of novel clinical stage drug candidates. | N/A | ||||
NovoStent Corp | N/A | |||||
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | N/A | ||||
Proprius Pharmaceuticals Inc | N/A |
Pagination
Team
Employee | Position | |||
---|---|---|---|---|
Standish M Fleming (founder) | [email protected] | |||
Ivor Royston (founder) | [email protected] | |||
Kristen Bailey | [email protected] | |||
Stuart J M Collinson | [email protected] |
Former team members
Employee | Company | Position | ||
---|---|---|---|---|
Julia Ronlov | Gen-Probe Inc | Associate Director
Business Development |